RSH 13.3% 3.4¢ respiri limited

The global remote patient monitoring system market size was...

  1. 588 Posts.
    lightbulb Created with Sketch. 288

    The global remote patient monitoring system market size was valued at USD 4.4 billion in 2022 and is expected to register a compound annual growth rate (CAGR) of 18.5% over the forecast period. COVID-19 has caused a significant impact on the industry. The remote monitoring systems serve with improved chronic disease management including early warning signs and progress tracker, thus boosting its demand at a global level. Chronic conditions account for 90% of the healthcare costs in the U.S. annually. This can be prevented by timely assistance provided to patients using a remote monitoring system.

    U.S. remote patient monitoring system market size, by product, 2020 - 2030 (USD Billion)


    The Respiri/Access collaboration has secured numerous RPM clients and also identified and progressed a number of immediate term significant potential payer contracts where Access have used wheezo® as a differentiated respiratory RPM device, expanded their offering to provide a full RPM service across all major disease states including cardiovascular, diabetes and obesity using other freely available medical devices.

    ”…..and progressed a number of IMMEDIATE TERM SIGNIFICANT POTENTIAL PAYER CONTRACTS…”

    Great acquisition - an amazing opportunity to grow on so many levels!!
    ”Immediate Term” - two or three months???


 
watchlist Created with Sketch. Add RSH (ASX) to my watchlist
(20min delay)
Last
3.4¢
Change
0.004(13.3%)
Mkt cap ! $36.03M
Open High Low Value Volume
3.0¢ 3.4¢ 3.0¢ $36.75K 1.184M

Buyers (Bids)

No. Vol. Price($)
1 224180 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 79999 1
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
3.4¢
  Change
0.004 ( 13.3 %)
Open High Low Volume
3.2¢ 3.4¢ 3.2¢ 71127
Last updated 14.52pm 03/05/2024 ?
RSH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.